Lung Calcification in Dogs (Pulmonary Calcinosis)
- Occurrence: very rare
- Location of disease: Chest
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
Pulmonary calcinosis in dogs is a condition in which calcium salts accumulate in the lung tissue, which can lead to breathing problems. This calcification can develop through two main mechanisms: dystrophic, when damaged tissue attracts calcium, or metastatic, when a high blood calcium level leads to deposits in healthy tissue. A common cause is hypercalcemia, which can be triggered by hormonal or metabolic disorders such as hyperparathyroidism, vitamin D overdose, or certain cancers. Kidney disease and toxic reactions to substances can also promote pulmonary calcinosis.
Symptoms include Cough, increased respiratory rate, and reduced exercise tolerance. The disease is usually diagnosed through X-rays, blood tests, and occasionally a lung biopsy. Treatment depends on the cause and may include normalizing calcium levels, discontinuing vitamin D intake, or cancer therapy. The prognosis depends on the underlying cause: while reversible causes offer a good prognosis, untreatable diseases can severely impair quality of life.
Preventive measures include a balanced diet and regular veterinary check-ups to detect early signs of metabolic disorders. Research focuses on the exact mechanisms of the disease, genetic factors, improved diagnostic methods, and new therapeutic approaches.
Ursachen
Pulmonary calcinosis is a pathological accumulation of calcium salts in the lung tissue. This phenomenon can be caused by both dystrophic and metastatic mechanisms. Dystrophic calcification occurs when already damaged or dead tissue attracts calcium, while metastatic calcification is the result of a systemic excess of calcium that deposits in healthy tissue.
An important aspect of pulmonary calcinosis is the ratio between calcium and phosphorus in the blood, which is often influenced by hormonal or metabolic disorders. Hypercalcemia, a condition of elevated calcium levels in the blood, is often associated with pulmonary calcinosis. This hypercalcemia can be caused by various diseases, such as hyperparathyroidism, vitamin D intoxication / poisoning, or certain cancers.
The causes of pulmonary calcinosis in dogs are varied. One of the most common causes is hypercalcemia, which can result from primary hyperparathyroidism or as a secondary response to chronic kidney disease. Toxic reactions to excessive vitamin D intake—either from supplements or from ingesting substances such as certain plants or rodenticides—can also play a role.
Cancer can also lead to pulmonary calcinosis. Tumors that produce parathyroid hormone-like substances can disrupt calcium regulation. These tumors are often part of paraneoplastic syndromes associated with lymphomas or adenocarcinomas. Chronic kidney disease can also lead to an imbalance of calcium and phosphorus, which promotes calcium deposition in the lungs.
Symptoms
Symptoms of pulmonary calcinosis can vary and depend on the severity and extent of the calcification. In the early stages, the disease may be asymptomatic, especially if the deposits are small and inconspicuous. As the disease progresses, however, clear clinical signs may develop.
A common symptom is shortness of breath, as the calcified areas of the lung lose their elasticity and gas exchange capacity. Dogs may also show a cough, which can be either dry or productive. In severe cases, cyanosis may occur, a bluish discoloration of the mucous membranes indicating a lack of oxygen in the blood.
Other symptoms can include general weakness, loss of appetite, and Weight loss. In some cases, Fever may occur, especially with a secondary infection. Since the symptoms are non-specific, it can be difficult to diagnose pulmonary calcinosis based on clinical signs alone.
Diagnose
Diagnosis of pulmonary calcinosis is usually made through a combination of clinical examination, medical history, and diagnostic imaging. Chest X-rays are often the first diagnostic tool for detecting lung calcification. These appear as bright, dense areas on the images. In some cases, computed tomography (CT) may be required to determine the exact extent of the calcification.
Blood tests are also important to identify the underlying causes of pulmonary calcinosis. Measuring calcium and phosphorus levels in the blood can provide information about possible metabolic disorders. An elevated calcium level may indicate hypercalcemia, while an imbalance between calcium and phosphorus may suggest chronic kidney disease or another underlying condition.
Additionally, a lung biopsy may be required to confirm the diagnosis and rule out other diseases. The biopsy allows for a microscopic examination of the lung tissue to assess the presence of calcium deposits as well as possible accompanying inflammatory changes.
Therapie
Treatment of pulmonary calcinosis depends on the underlying cause. In cases of hypercalcemia, treatment aims to normalize blood calcium levels. This can be done by administering medications that reduce calcium absorption or increase calcium excretion via the kidneys.
In cases of vitamin D intoxication / poisoning, treatment usually consists of the immediate discontinuation of vitamin D intake, support of kidney function through fluid therapy, and other supportive measures. In cases where cancer is the cause, chemotherapy or radiation therapy may be required to shrink the tumor and reduce paraneoplastic effects.
In some cases, particularly with chronic kidney disease, long-term treatment may be necessary to slow the progression of calcification and alleviate symptoms. Dietary adjustments, including a reduction in calcium and phosphorus intake, can also be helpful.
Prognose und Nachsorge
The prognosis for dogs with pulmonary calcinosis depends heavily on the underlying cause and the course of the disease. In cases where the cause can be successfully treated, such as reversible hypercalcemia, the prognosis is generally favorable.
However, if pulmonary calcinosis is due to an untreatable or progressive disease, such as certain cancers or severe kidney disease, the prognosis may be poorer. Early diagnosis and intervention are crucial to achieving the best results.
In cases of severe lung calcification leading to significant Respiratory distress, the dog’s quality of life may be severely impaired, and the prognosis may be unfavorable. In such cases, it is important to assess the animal’s quality of life and make humane decisions.
Prävention
Prevention of pulmonary calcinosis in dogs primarily involves avoiding the underlying causes where possible. A balanced diet that does not contain excessive amounts of vitamin D or calcium is crucial, especially for dogs prone to metabolic diseases.
Regular veterinary check-ups can help detect early signs of metabolic disorders before they lead to pulmonary calcinosis. This is especially important for older dogs or those prone to chronic illnesses.
For dogs at increased risk of cancer, regular health checks and, if necessary, early diagnosis programs can help prevent the development of paraneoplastic syndromes that can lead to pulmonary calcinosis.
Ausblick auf aktuelle Forschung
Pulmonary calcinosis, also known as lung calcification, is a condition in which calcium salts are deposited in the lungs. These calcifications can impair normal lung function and lead to breathing problems. The causes of this disease are varied, ranging from systemic diseases to local lung changes. Current research is intensively searching for the exact mechanisms that contribute to the development of pulmonary calcinosis, as well as for new diagnostic and treatment options.
One research focus is on investigating the role of metabolic diseases, particularly hypercalcemia, in the development of pulmonary calcinosis. Hypercalcemia, a condition of elevated calcium levels in the blood, can be caused by various diseases, including hyperparathyroidism and certain tumor diseases. Research is investigating how these systemic diseases lead to calcium deposition in the lungs and which molecular pathways play a role.
Another area of research deals with the genetic factors that could contribute to pulmonary calcinosis. There is evidence that certain genetic predispositions increase the risk of developing this disease. Genome-wide association studies (GWAS) and other genetic analyses are being used to identify specific genes and genetic variants associated with pulmonary calcinosis.
The development of new diagnostic methods is also an active field of research. Currently, pulmonary calcinosis is often diagnosed using X-rays or CT scans, which, however, only make advanced stages of the disease visible. Researchers are working on developing biomarkers that could enable earlier detection, as well as improving imaging techniques to detect and quantify calcium deposits more precisely.
New therapeutic approaches are also being investigated. While treating the underlying cause of pulmonary calcinosis is often a priority, there is growing interest in developing specific therapies that directly address the calcium deposits. Experimental approaches aimed at modulating calcium metabolism or promoting the resorption of calcium deposits are the subject of current studies.
Overall, research on pulmonary calcinosis aims to gain a better understanding of the pathophysiology of this disease in order to develop more precise diagnostic tools and more effective treatment strategies. Interdisciplinary collaboration between veterinarians, biochemists, and geneticists plays a crucial role in this.
Frequently Asked Questions (FAQs)
1. What is pulmonary calcinosis in dogs?
2. What are the causes of pulmonary calcinosis in dogs?
3. How is pulmonary calcinosis diagnosed?
4. What symptoms does a dog with pulmonary calcinosis show?
5. Can pulmonary calcinosis be cured?
6. Are there risk factors for the development of pulmonary calcinosis?
7. What treatment options are available for dogs with pulmonary calcinosis?
8. Is pulmonary calcinosis common in dogs?
9. Can environmental factors contribute to pulmonary calcinosis?
10. How can I help my dog with pulmonary calcinosis?
Literatur
- Berry, C. R., Ackerman, N., & Monce, K. (1994). Pulmonary mineralization in four dogs with Cushing’s syndrome. Veterinary Radiology & Ultrasound, 35(1), 10–16. https://doi.org/10.1111/j.1740-8261.1994.tb00170.x
- Berry, C. R., Hawkins, E. C., Hurley, K. J., & Monce, K. (2000). Frequency of pulmonary mineralization and hypoxemia in 21 dogs with pituitary-dependent hyperadrenocorticism. Journal of Veterinary Internal Medicine, 14(2), 151–156. https://doi.org/10.1111/j.1939-1676.2000.tb02229.x
- Blois, S. L., Caron, I., & Mitchell, C. (2009). Diagnosis and outcome of a dog with iatrogenic hyperadrenocorticism and secondary pulmonary mineralization. Canadian Veterinary Journal, 50(4), 397–400.
- Jorge, K. M., Huguet, E. E., Finley, A., Dulaney, D. R., Cocchiaro, M., Montiel-Del Valle, A., & Berry, C. R. (2021). Radiographic characteristics of alveolar microlithiasis and pulmonary ossification following chronic corticosteroid therapy in a dog. Veterinary Radiology & Ultrasound, 62(3), E30–E34. https://doi.org/10.1111/vru.12787
- Sousa, A. C., Santos, J. C., Landolt, C., Gomes, C., Dias-Pereira, P., & Baptista, C. S. (2020). Clinicopathological and imaging features of pulmonary alveolar microlithiasis in a dog: A case report. BMC Veterinary Research, 16, Article 376. https://doi.org/10.1186/s12917-020-02593-z
- Brix, A. E., Latimer, K. S., Moore, G. E., & Roberts, R. E. (1994). Pulmonary alveolar microlithiasis and ossification in a dog. Veterinary Pathology, 31(3), 382–385. https://doi.org/10.1177/030098589403100314
- de Brot, S., & Hilbe, M. (2013). Pulmonary alveolar microlithiasis with concurrent pleural mesothelioma in a dog. Journal of Veterinary Diagnostic Investigation, 25(6), 798–802. https://doi.org/10.1177/1040638713504571